Phosphodiesterase Type 5 Inhibitors Increase Herceptin Transport and Treatment Efficacy in Mouse Metastatic Brain Tumor Models

Jinwei Hu, Julia Y. Ljubimova, Satoshi Inoue et al. · 2010

Read Phosphodiesterase Type 5 Inhibitors Increase Herceptin Transport and Treatment Efficacy in Mouse Metastatic Brain Tumor Models by Jinwei Hu, Julia Y. Ljubimova, Satoshi Inoue et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0010108.txt.

Description

The authors were Jinwei Hu, Julia Ljubimova, Satoshi Inoue, and others. Their 2010 PLOS ONE study tackled drug delivery to brain tumors in mice. Most cancer drugs reach body tumors well enough. Brain tumors hide behind a blood-brain tumor barrier that keeps many drugs out, sharply limiting treatment there.

The team tested type 5 phosphodiesterase inhibitors, a known drug class, as helpers. In mouse models of metastatic brain tumors, those drugs raised transport of Herceptin, an antibody drug. They also improved how well that treatment worked, offering a route around the barrier.

Catalog record

CREATORJinwei Hu, Julia Y. Ljubimova, Satoshi Inoue et al.
YEAR2010
COLLECTIONPAPERS
FORMATTXT
FILE SIZE46 KB
LICENSECreative Commons Attribution License
RIGHTSCC BY
SOURCEPLOS ONE

Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0010108

Browse the full library · About the Tower of Babel